Portal de Periódicos da CAPES

Burden of Clostridium difficile on the Healthcare System

2012; Oxford University Press; Volume: 55; Issue: suppl_2 Linguagem: Inglês

10.1093/cid/cis335

1537-6591

Erik R. Dubberke, Margaret A. Olsen,

Microscopic Colitis

There are few high-quality studies of the costs of Clostridium difficile infection (CDI), and the majority of studies focus on the costs of CDI in acute-care facilities. Analysis of the best available data, from 2008, indicates that CDI may have resulted in $4.8 billion in excess costs in US acute-care facilities. Other areas of CDI-attributable excess costs that need to be investigated are costs of increased discharges to long-term care facilities, of CDI with onset in long-term care facilities, of recurrent CDI, and of additional adverse events caused by CDI.